Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage

Synapse

Volumn 32, Issue 2, 1999, Pages 71-79

  Heinz, Andreas ^a   Saunders, Richard C ^a   Kolachana, Bhaskar S ^a   Jones, Douglas W ^a   Gorey, Julia G ^a   Bachevalier, Jocelyne ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

CIT SPECT; IBZM SPECT; Neurodevelopmental hypothesis; Phasic dopamine release; Prefrontal regulation

Indexed keywords

CITALOPRAM; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; IODINE 123; MONOAMINE; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; LIMBIC CORTEX; MALE; MICRODIALYSIS; MONOAMINERGIC SYSTEM; NEWBORN; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RHESUS MONKEY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL CORTEX;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BENZAMIDES; BINDING, COMPETITIVE; CARRIER PROTEINS; COCAINE; CONTRAST MEDIA; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IODINE RADIOISOTOPES; LIMBIC SYSTEM; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICRODIALYSIS; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; PYRROLIDINES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033561362     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199905)32:2<71::AID-SYN1>3.0.CO;2-Q     Document Type: Article

References (42)

1. Abercrombie ED, Keefe KA, Di Frischia DS, Zigmond MJ. 1989. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 52: 1655-1658.
2. Baldwin RM, Zea-Ponce Y, Zoghbi SS, Laruelle, M Al-Tikriti, MS Sybirska EH, Malison RT, Neumeyer JL, Milius RA, Wang S, Stabin M, Smith EO, Charney DS, Hoffer PB, Innis RB. 1993. Evaluation of the monoamine uptake site ligand [123-I]methyl 3-(Iodophenyl)-tropane-2-carboxylate ([123-I]-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI. Nucl Med Biol 5: 597-606.
3. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. 1998. Altered development of prefrontal neurons in rhesus monkeys with neonatal medial temporolimbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 7:740-748.
4. Bowers MB Jr, Malison RT, Seibyl JP, Kosten TR. 1998. Plasma homovallinic acid and the dopamine transporter during cocaine withdrawal. Biol Psychiatry 43: 278-281.
5. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, Weinberger DR, Weisenfels N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94: 2569-2574.
6. Deutch AY, 1992. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm (Suppl) 36: 61-89.
7. Giros B, Jaber M, Jones SR, Wightman MR, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
8. Goldman-Rakic PS, Leranth C, Williams SM, Mons N, Geffard M. 1989. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA 86: 9015-9019.
9. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neurosci 41:1-24.
10. Imperato A, Di Chiara G. 1986. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Res 239: 219-228.
11. Kalivas PW, Duffy P. 1989. Similar effects of daily cocaine and stress on mesocortical dopamine neurotransmission in the rat. Biol Psychiatry 25: 913-928.
12. Kalivas PW, Duffy P, Barrow J. 1989. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251: 378-387.
13. Krebs MO, Desce JM, Kemel ML, Gauchy C, Godeheu G, Cheramy A, Glowinski J. 1991. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56:81-85.
14. Knable MB, Jones DW, Coppola R, Hyde TM, Lee KS, Gorey J, Weinberger DR. 1995. Lateralized differences in Iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease. J Nucl Med 36: 1216-1225.
15. Kolachana BS, Saunders RC, Weinberger DR. 1995. Augmentation of prefrontal monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey. Neuroscience 69: 859-868.
16. Kuikka JT, Tiihonen J, Bergstrom KA, Karhu J, Hartikainen P, Viinamaki H, Lnasimies E, Lehtonen J, Hakola P. 1995. Imaging of dopamine and serotonin transporters in the living human brain. Eur J Nucl Med 22: 346-350.
17. Kung MP, Kung H. 1989. Peracetic acid as a superior oxidant for preparation of I-123-IBZM; a potential dopamine D2 receptor imaging agent. J Radiopharm Lab Comp 27: 691-700.
18. Kung H, Alavi A, Chang W, Kung MP, Keyes JW, Velchik MG, Billings J, Pan S, Noto R, Rausch A, Reilly J. 1990. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. J Nucl Med 31:573-579.
19. Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, Al-Tikriti MS, Sybirska EH, Zimmermann RC, Wiesniewski G, Neumeyer JL, Milius RA, Wang S, Smith EO, Roth RH, Charney DS, Hoffer PB, Innis RB. 1993. SPECT imaging of dopamine and serotonin transporters with [123-I]β-CIT: pharmacological characterization of brain uptake in non-human primates. Synapse 13: 295-309.
20. Laruelle M, Wallace E, Seibyl JP, Baldwin RM, Zea-Ponce Y, Zoghbi SS, Neumeyer JL, Charney DS, Hoffer PB, Innis RB. 1995. Graphical, kinetic, and equilibrium analyses of in vivo [123-I]-CIT binding to dopamine transporters in healthy human subjects. J Cerebr Blood Flow Metab 14: 982-994.
21. Laruelle M, Abi-Dargham, A van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93: 9235-9240.
22. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW. 1997. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in non-human primate. Synapse 25: 1-14.
23. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg B, Petri S, Benjamin J, Mueller C, Hamer DH, Murphy DL. 1996. Association of anxiety-related traits with a polymorphism of the sertotonin transporter gene regulatory region. Science 274: 1527-1531.
24. Lewis DA. 1997. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16: 385-398.
25. Lipska BK, Jaskiw GE, Weinberger DR. 1993. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9: 67-75.
26. Lipska BK, Swerdlow NR, Geyer, MA, Jaskiw JE, Braff DL, Weinberger DR. 1995. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122: 35-43.
27. Louilot A, Le Moal M, Simon H. 1989. Opposite influences of dopaminergic pathways in the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltametric study. Neuroscience 29: 45-56.
28. Mac Dermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL. 1986. NMDA-receptor activation increases cytoplasmic calcium concentrations in cultured spinal cord neurons. Nature 321:519-522.
29. May T. 1992. Striatal dopamine D1-like receptors have higher affinity for dopamine in ethanol-treated rats. Eur J Pharmacol 215: 313-316.
30. Mereu G, Fadda F, Gessa GL. 1984. Ethanol stimulates the firing rate of nigral dopamine neurons in unanesthetized rats. Brain Res 292: 63-69.
31. Moghaddam B, Adams B, Verma A, Daly D. 1997. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927.
32. Saunders RC, Kolachana BS, Weinberger DR. 1993. Local pharmacological manipulation of dopamine in the prefrontal cortex and caudate in the rhesus monkey, an in vivo microdialysis study. Exp Brain Res 98: 44-52.
33. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR. 1997. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 393:169-171.
34. Seeman P. 1995. Therapeutic receptor-blocking concentrations of neuroleptics. Int Clin Psychopharmacol 10: 5-13.
35. Sesack SR, Bressler CN, Lewis DA. 1995. Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: a study of calretininin-immunoreactive cells. Neurosc Lett 200: 9-12.
36. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S, Zea-Ponce Y, Gao Y, Zhang WY, Neumeyer JL, Zubal IG, Charney DS, Hoffer PB, Innis RB. 1994. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with Iodine-123-βCIT in healthy human subjects. J Nucl Med 35: 764-770.
37. Taber MT, Das S, Fibiger HC. 1995. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 65: 1407-1410.
38. Weinberger DR. 1996. On the plausibility of the neurodevelopmental hypothesis'of schizophrenia. Neuropsychopharmacol 14: 1S-11S
39. Weinberger DR, Lipska BK. 1995. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 16: 87-110.
40. Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:66-669.
41. Weinberger DR, Berman KF, Suddath R, Torrey EF. 1992. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 149: 890-897.
42. Westerink BHC, Kwint HF, de Vries JB. 1996. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosc 16: 2605-2611.